Lana Medical Co.

Lana Medical Co.

9587.SR
Lana Medical Co.SA flagSaudi Exchange
2.66
SAR
+0.02
- -
143.64MMarket Cap
Lana Medical Co.
9587.SR
(Saudi Exchange)

Recent

price

2.66

P/E

ratio

- -

div

yld

- -

ROIC.AI

2017
2018
2019
2020
2021
2022
2023
2024
2025
FRC
- -
0.25
0.22
0.39
0.59
0.76
1.07
1.56
- -
Revenue per Share
- -
-0.04
0.05
0.08
0.12
0.1
-0.04
0.23
- -
Basic EPS, GAAP
- -
0.01
0.05
0.01
-0.09
0.1
-0.06
-0.07
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
0.85
- -
Book Value per Share
- -
0.24
0.29
0.41
0.77
0.88
1.49
1.13
- -
Tangible Book Value per Share
- -
54
54
54
54
54
46
54
- -
Basic Weighted Avg Shares
- -
13
12
21
32
41
49
84
92
Sales/Revenue/Turnover
- -
-13.18
21.86
21.86
22.9
16.09
0.63
10.57
7.45
Operating Margin (%)
- -
- -
- -
- -
- -
- -
2
4
6
Depreciation Expense
- -
-2
3
4
7
5
-2
12
3
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
8.51
28.11
Effective Tax Rate (%)
- -
-15.13
22.47
19.9
20.63
13.46
-3.96
14.82
2.92
Profit Margin (%)
15
16
18
22
35
34
53
27
31
Working Capital
- -
- -
- -
- -
- -
- -
- -
8
10
LT Debt
15
13
16
22
42
47
68
61
65
Total Equity
- -
- -
17.29
24.05
22.88
14.75
- -
13.29
7.57
Return on Invested Capital (%)
- -
- -
388.53
1,125.77
2,565.9
- -
- -
41.04
6.14
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
54.19
5.24
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
28.81%
6.77%
Free Cash Flow
- -
-303.49%
178.18%
Net Income, GAAP
- -
-183.95%
-78.36%
Sales/Revenue/Turnover
- -
36.24%
9.77%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
49
2024
- -
- -
- -
- -
84
2025
- -
- -
- -
- -
92

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
-0.04
2024
- -
- -
- -
- -
0.23
2025
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
Business
Lana Medical Company engages in the manufacture and supply of medical devices and equipment primarily for private and government healthcare sectors in the Kingdom of Saudi Arabia. Its core products and services include medical consumables and supplies; medical waste management services; medical equipment maintenance; and infection control services. The company’s product portfolio covers a broad range of medical devices and plastic medical supplies, supported by its factory operations and recent expansion efforts in medical-grade plastic products. Founded in 2010 and headquartered in Riyadh, Saudi Arabia, Lana Medical has established a footprint in healthcare equipment manufacturing and services. Recent major developments include a strategic expansion of its plastic medical supplies factory to double production capacity and broaden product offerings, alongside the acquisition of Kian Plastic Factory, repositioning the latter for producing medical and non-medical plastic products. In addition, the company secured a SAR 5.6 million project contract with the Saudi Red Crescent and implemented a stock split reducing the par value of shares from SAR 10 to SAR 1, enhancing liquidity. Lana Medical’s efforts reflect an ongoing growth strategy focusing on strengthening its market position in medical equipment and healthcare services within Saudi Arabia, leveraging manufacturing capability expansions and key public sector partnerships.